Australian Clinical Labs Health Care

$3.44 0.04 (1.18%)

High $3.45	Low $3.39	Trades 1,017	Turnover $1,031,103	Volume 301,613
30 June 2023 at 4:10pm

Register to track ACL and receive email alerts.

Market Cap (1-Jul) $551,858,752 (281st)	Close (30-Jun) $3.44 0 (0%)	Volume (30-Jun) 301,613	Shortsold (19-Jun) 5,228,888 (2.66%) (98th)
52w High $3.81	52w Low $2.23	P/E 13.62	EPS 0.15

	Subject
	ACL ACL Ann: HLS: Directors' Statement re Takeover
	1 (current) 2 3
	ACL ACL Ann: Response to Healius' Target's Statement
	ACL ACL Ann: Second Supplementary Bidder's Statement
	ACL ACL Ann: Takeover offer - receipt of Target's Statement
	ACL ACL Ann: HLS: Lodgement of Target's Statement
	ACL ACL Ann: Completion of dispatch of replacement bidder's statement
	ACL ACL Ann: Commencement of dispatch of replacement bidder's statement
	ACL ACL Ann: Notice of EGM
	ACL ACL Ann: TOV: HLS Panel Declines to Conduct Proceedings
	ACL ACL Ann: ASX announcement - Replacement Bidder's Statement
	ACL ACL Ann: Replacement Bidder's Statement
	ACL ACL Ann: First Supplementary Bidder's Statement
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: TOV: HLS Panel Receives Application
	ACL ACL Ann: Update - Dividend/Distribution - ACL
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Suspension of DRP
	ACL ACL Ann: HLS: Directors' Statement re Takeover
	ACL ACL Ann: Proposed issue of securities - ACL
	ACL ACL Ann: Becoming a substantial holder for HLS
	ACL ACL Ann: People to whom information is to be sent
	ACL ACL Ann: HLS: Off-market takeover bid from ACL
	ACL ACL Ann: Investor Webinar - Takeover Offer for Healius
	ACL ACL Ann: Investor Presentation - Takeover Offer for Healius
	ACL ACL Ann: Bidder's Statement in relation to Takeover Offer for Healius
	ACL ACL Ann: Takeover Offer for Healius Limited
	ACL ACL Ann: Notification regarding unquoted securities - ACL
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Notification regarding unquoted securities - ACL
	ACL ACL Ann: Notification of cessation of securities - ACL
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Dividend/Distribution - ACL
	ACL ACL Ann: 1H23 results investor presentation
	ACL ACL Ann: Appendix 4D and 1H23 financial reports
	ACL ACL Ann: 1H23 Financial Results release details
	ACL ACL Ann: Release of Shares from Voluntary Escrow
	ACL ACL Ann: Medlab Cyber Incident Update
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Medlab Pathology Cyber Incident
	ACL ACL Ann: 2022 AGM - Results of Meeting
	ACL ACL Ann: 2022 AGM - addresses to shareholders
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Director Appointment/Resignation
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Ceasing to be a substantial shareholder
	ACL ACL Ann: 2022 Annual Report and Corporate Governance Statement
	ACL ACL Ann: Appendix 4G

Register to track ACL and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
30-Jun	$2.78	596,955	-0.02 (0.71%)
27-Jun	$2.80	551,440	+0.08 (2.94%)
26-Jun	$2.72	810,747	+0.01 (0.37%)
24-Jun	$2.71	571,518	+0.08 (3.04%)
23-Jun	$2.63	595,336	+0.01 (0.38%)
20-Jun	$2.62	3,412,732	-0.07 (2.60%)
19-Jun	$2.69	581,114	-0.04 (1.47%)
18-Jun	$2.73	913,300	-0.02 (0.73%)
16-Jun	$2.75	577,986	+0.02 (0.73%)
13-Jun	$2.73	774,648	-0.09 (3.19%)
12-Jun	$2.82	720,385	+0.05 (1.81%)
06-Jun	$2.77	2,811,277	-0.01 (0.36%)
05-Jun	$2.78	423,316	0.00 (0.00%)
04-Jun	$2.78	630,614	-0.01 (0.36%)
03-Jun	$2.79	3,417,740	-0.03 (1.06%)
6 up, 8 down, and 1 flat days